Choledocholithiasis: A Comprehensive Overview

Introduction

Choledocholithiasis is a medical condition characterised by the presence of one or more gallstones in the common bile duct (CBD). The bile duct is a small tube that carries bile from the liver and gallbladder to the duodenum (the first part of the small intestine). When stones block this passage, they can lead to a variety of complications, ranging from mild discomfort to life-threatening infections.

Anatomy and Physiology of the Biliary System

The biliary system consists of the liver, gallbladder, and bile ducts. Bile, a digestive fluid produced by the liver, is stored in the gallbladder and released into the small intestine to aid in the digestion of fats. The common bile duct is a crucial conduit, formed by the union of the cystic duct (from the gallbladder) and the common hepatic duct (from the liver). Any obstruction in this duct, such as by gallstones (choledocholithiasis), disrupts the flow of bile, leading to clinical symptoms.

Causes and Risk Factors

Choledocholithiasis is most commonly caused by gallstones that have migrated from the gallbladder into the common bile duct. These stones are typically composed of cholesterol, bilirubin, or a mixture of both. The main risk factors include:

• Gallstones (Cholelithiasis): Most patients with choledocholithiasis have a history of gallstones.
• Age: The risk increases with age, particularly after the age of 40 years.
• Gender: Women are more commonly affected than men, possibly due to hormonal influences.
• Obesity and Metabolic Syndrome: Higher body mass index and metabolic abnormalities contribute to stone formation.
• Rapid Weight Loss: Sudden weight reduction, as seen after bariatric surgery, can increase stone formation.
• Ethnicity and Genetics: Certain populations, including North Indians, have a higher prevalence of gallstones.
• Haemolytic Disorders: Conditions leading to increased breakdown of red blood cells can result in pigment stones.

Pathophysiology

Gallstones, formed in the gallbladder, may pass into the common bile duct. Once lodged, they cause partial or complete obstruction of bile flow. This leads to increased pressure in the biliary system, inflammation, and sometimes infection (cholangitis). Prolonged obstruction may also cause jaundice and can damage the liver or pancreas, resulting in serious complications like pancreatitis.

Clinical Presentation

The symptoms of choledocholithiasis vary based on the degree of obstruction and presence of complications. Common presentations include:

• Abdominal Pain: Usually in the right upper quadrant or epigastric region, sometimes radiating to the back or right shoulder.
• Jaundice: Yellowish discolouration of the skin and eyes due to the accumulation of bilirubin.
• Fever and Chills: May indicate associated infection (cholangitis).
• Dark Urine and Pale Stools: Due to reduced bile flow into the intestine.
• Nausea and Vomiting: Common in acute cases.

Some patients may remain asymptomatic, and the condition is discovered incidentally during imaging for other reasons.

Complications

Untreated choledocholithiasis can result in several serious complications, including:

• Acute Cholangitis: Infection of the biliary tract, a medical emergency.
• Acute Pancreatitis: Inflammation of the pancreas if the stone blocks the pancreatic duct.
• Biliary Cirrhosis: Chronic obstruction can cause progressive liver damage.
• Sepsis: Severe infection spreading to the bloodstream.

Diagnosis

The diagnosis of choledocholithiasis involves a combination of clinical assessment, laboratory tests, and imaging studies.

• Blood Tests: Elevated liver enzymes (ALT, AST, ALP, GGT), increased bilirubin, and sometimes raised white cell count.
• Ultrasound Abdomen: First-line imaging; may show dilated bile ducts and sometimes the stones.
• Magnetic Resonance Cholangiopancreatography (MRCP): Non-invasive imaging to visualise the biliary tree and detect stones.
• Endoscopic Retrograde Cholangiopancreatography (ERCP): Both diagnostic and therapeutic; allows direct visualisation and removal of stones.
• CT Scan: Useful for detecting complications or if ultrasound is inconclusive.

In India, ultrasound is widely available and often the initial investigation of choice due to cost and accessibility.

Treatment Options

The management of choledocholithiasis depends on the size, number, and location of the stones, as well as the patient’s overall health and presence of complications. Treatment approaches include:

1. Endoscopic Removal (ERCP): The preferred method for removing CBD stones. During ERCP, a flexible endoscope is passed through the mouth into the duodenum, and special instruments are used to extract stones.
2. Surgical Removal: In cases where ERCP is unsuccessful or not available, surgery may be performed. This may involve open or laparoscopic exploration of the CBD.
3. Cholecystectomy: Removal of the gallbladder is often recommended after clearance of the CBD to prevent recurrence of stones.
4. Medical Management: Supportive care with intravenous fluids, antibiotics (if infection is present), and pain management. Oral dissolution therapy is rarely effective for CBD stones.

In rural or resource-limited settings in India, access to ERCP may be limited, and patients may require referral to tertiary care centres.

Prognosis and Prevention

With timely intervention, the prognosis of choledocholithiasis is generally good. However, delayed treatment can lead to significant morbidity and even mortality. Preventive measures include:

• Maintaining a healthy weight
• Regular physical activity
• Dietary modifications to reduce cholesterol intake
• Early management of gallstones

In India, increasing awareness about gallstone disease and its complications is essential to improve outcomes, especially in rural populations.

Nursing Care of Patients with Choledocholithiasis

Nursing care for patients with choledocholithiasis demands a thorough understanding of the disease process, vigilant assessment, prompt intervention, patient education, and multidisciplinary collaboration to optimize patient outcomes.

Assessment and Diagnosis

Nurses play a pivotal role in the early identification and monitoring of symptoms suggestive of choledocholithiasis.

• Obtain a detailed patient history, including onset and pattern of pain, associated symptoms, and risk factors (such as a history of gallstones, obesity, rapid weight loss, hemolytic disorders).
• Conduct focused physical assessment, noting signs such as Murphy’s sign, jaundice, or palpable gallbladder.
• Monitor vital signs for fever, tachycardia, hypotension, or indications of sepsis.
• Review laboratory findings: elevated bilirubin, alkaline phosphatase, AST, ALT, white blood cell count.
• Assist with diagnostic imaging: ultrasound, MRCP (Magnetic Resonance Cholangiopancreatography), ERCP (Endoscopic Retrograde Cholangiopancreatography), or CT scan.

Nursing Diagnoses

• Acute pain related to biliary obstruction and inflammation
• Risk for infection related to stasis of bile and potential for ascending cholangitis
• Impaired skin integrity related to pruritus and jaundice
• Imbalanced nutrition: less than body requirements due to nausea and vomiting
• Deficient knowledge regarding disease process, treatment options, and prevention of recurrence
• Anxiety related to acute illness and hospitalization

Nursing Interventions

Pain Management

• Assess pain characteristics, intensity, and response to interventions regularly.
• Administer prescribed analgesics (e.g., opioids, NSAIDs) as ordered, observing for side effects such as respiratory depression or gastrointestinal upset.
• Encourage relaxation techniques and provide a calm environment to reduce pain perception.
• Position patient for comfort, such as semi-Fowler’s to reduce abdominal tension.

Monitoring and Preventing Infection

• Monitor temperature and other signs of infection (such as leukocytosis, chills, hypotension).
• Initiate and monitor intravenous antibiotic therapy as prescribed.
• Maintain aseptic technique with all invasive devices and procedures.
• Observe for signs of sepsis and report promptly to the healthcare team.

Nutritional Support

• Assess nutritional status and monitor for signs of malnutrition (weight loss, poor intake, weakness).
• Implement NPO (nothing by mouth) status if instructed, especially prior to procedures such as ERCP or surgery.
• When allowed, provide a low-fat diet to reduce biliary stimulation and discomfort.
• Administer antiemetics as prescribed to control nausea and vomiting.
• Monitor fluid and electrolyte balance, and provide IV fluids as ordered.

Skin Care

• Monitor for pruritus and integrity of skin, particularly in jaundiced patients.
• Encourage use of mild soaps and moisturizers; avoid hot water and harsh scrubbing.
• Keep nails trimmed and encourage the use of mittens or gloves if scratching is severe.
• Apply prescribed topical treatments for itching as needed.

Education and Emotional Support

• Provide information regarding the nature of choledocholithiasis, possible procedures (ERCP, cholecystectomy), and post-procedure expectations.
• Discuss potential complications and the importance of reporting new or worsening symptoms promptly.
• Offer psychological support and encourage the expression of fears and concerns.
• Involve family members in education and care planning as appropriate.

Collaborative Management

Close teamwork with the medical team is essential. Nurses should:

• Assist with and prepare patients for diagnostic and therapeutic procedures, such as ERCP (with possible stone extraction or stent placement) or surgical interventions (open or laparoscopic cholecystectomy).
• Monitor for and manage post-procedural complications, such as pancreatitis, bleeding, infection, or perforation.
• Ensure accurate documentation of all assessments, interventions, and patient responses.
• Coordinate with dietitians, pharmacists, and other specialists to ensure comprehensive patient care.

Discharge Planning and Home Care

To reduce the risk of recurrence and promote optimal recovery, discharge planning should include:

• Instruction on recognition of signs of complications, such as persistent jaundice, fever, or severe pain.
• Guidance on maintaining a healthy, low-fat diet and gradual resumption of normal activities.
• Education on medication management, including antibiotics or analgesics as prescribed.
• Recommendations for regular follow-up with healthcare providers.
• Advice on maintaining hydration and monitoring for changes in urine and stool color.

Patient and Family Education

Effective education empowers patients and families to participate actively in care:

• Emphasize the importance of adhering to prescribed treatments and follow-up appointments.
• Provide clear instructions on wound care if surgical intervention was performed.
• Discuss lifestyle modifications to reduce risk factors for gallstone formation, such as weight management, balanced nutrition, and regular physical activity.

Special Considerations

• Older adults and immunocompromised patients may present with atypical symptoms or be at higher risk for complications; close monitoring is essential.
• Consider cultural and language differences that may affect understanding and compliance.
• Address unique needs of patients with comorbidities, such as diabetes or chronic liver disease.

REFERENCES

1. Osmosis. Choledocholithiasis: What Is It, Causes, Diagnosis, Treatment, and More. https://www.osmosis.org/answers/choledocholithiasis .
2. McNicoll CF, Pastorino A, Farooq U, et al. Choledocholithiasis. [Updated 2023 Jul 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441961/
3. Medline Plus. Choledocholithiasis. https://medlineplus.gov/ency/article/000274.htm.
4. Bosley ME, Zamora IJ, Neff LP. Choledocholithiasis-a new clinical pathway. Transl Gastroenterol Hepatol. 2021 Jul 25;6:35. doi: 10.21037/tgh-20-172. PMID: 34423156; PMCID: PMC8343507.
5. Merck Manual Professional Version. Choledocholithiasis and Cholangitis.. https://www.merckmanuals.com/professional/hepatic-and-biliary-disorders/gallbladder-and-bile-duct-disorders/choledocholithiasis-and-cholangitis.
6. Molvar C, Glaenzer B. Choledocholithiasis: Evaluation, Treatment, and Outcomes. Semin Intervent Radiol. 2016 Dec;33(4):268-276. doi: 10.1055/s-0036-1592329. PMID: 27904245; PMCID: PMC5088099.
7. Cianci P, Restini E. Management of cholelithiasis with choledocholithiasis: Endoscopic and surgical approaches. World J Gastroenterol. 2021 Jul 28;27(28):4536-4554. doi: 10.3748/wjg.v27.i28.4536. PMID: 34366622; PMCID: PMC8326257.

Stories are the threads that bind us; through them, we understand each other, grow, and heal.

JOHN NOORD

Connect with “Nurses Lab Editorial Team”

I hope you found this information helpful. Do you have any questions or comments? Kindly write in comments section. Subscribe the Blog with your email so you can stay updated on upcoming events and the latest articles.